Issue 60, 2017

Recent advances in the rational design of copper chalcogenide to enhance the photothermal conversion efficiency for the photothermal ablation of cancer cells

Abstract

Copper chalcogenide nanoparticles have received increased attention as photothermal agents due to their low cost and easy preparation. Nevertheless, the underdeveloped photothermal conversion efficiency of copper chalcogenide has limited its further application for cancer therapy. Thus, enhancing the photothermal conversion efficiency of copper chalcogenide through rational design is desired. In this review, we have discussed three kinds of rational design and a mechanism for copper chalcogenide to enhance the heat conversion efficiency in detail and briefly introduced their application in photothermal therapy. First is the design and synthesis of the superstructure nanoparticle agents to enhance photon refraction. Then, tuning the degree of copper deficiency enhances the localized surface plasmon resonance absorption caused by copper chalcogenide. The rest is constructing the hybrid composite to further enhance the localized surface plasmon resonance absorption through the coupling effect of different functional units. Despite higher photothermal conversion efficiencies and better therapeutic effects for cancer achieved through rational design, there still exists a challenge to be addressed, as well as promise for rational design facing the keen research and discuss before clinical applications of copper chalcogenide.

Graphical abstract: Recent advances in the rational design of copper chalcogenide to enhance the photothermal conversion efficiency for the photothermal ablation of cancer cells

Article information

Article type
Review Article
Submitted
15 May 2017
Accepted
17 Jul 2017
First published
01 Aug 2017
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2017,7, 37887-37897

Recent advances in the rational design of copper chalcogenide to enhance the photothermal conversion efficiency for the photothermal ablation of cancer cells

C. Yan, Q. Tian and S. Yang, RSC Adv., 2017, 7, 37887 DOI: 10.1039/C7RA05468H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements